Screening and outcomes in biliary atresia: Summary of a national institutes of health workshop

Hepatology

Volumn 46, Issue 2, 2007, Pages 566-581

  Sokol, Ronald J ^a,f   Shepherd, Ross W ^b   Superina, Riccardo ^c   Bezerra, Jorge A ^d   Robuck, Patricia ^e   Hoofnagle, Jay H ^e  

^a Nutrition Obesity Research Center at the University of Colorado   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHILDREN'S MEMORIAL HOSPITAL   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^f CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN GLUCURONIDE; CORTICOSTEROID; PREDNISOLONE; URSODEOXYCHOLIC ACID;

BILE DUCT ATRESIA; BILE DUCT OBSTRUCTION; CHOLESTASIS; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG MEGADOSE; FECES ANALYSIS; HISTOPATHOLOGY; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; LOW DRUG DOSE; PATHOGENESIS; PORTOENTEROSTOMY; PRIORITY JOURNAL; UNITED STATES;

ANIMALS; BILIARY ATRESIA; HUMANS; LIVER TRANSPLANTATION; PORTOENTEROSTOMY, HEPATIC; TREATMENT OUTCOME;

EID: 34548319067     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21790     Document Type: Conference Paper

References (121)

1. Mack CL, Sokol RJ. Unraveling the pathogenesis and etiology of biliary atresia. Pediatr Res 2005;57:R87-R94.
2. Kahn E. Biliary atresia revisited. Pediatr Dev Pathol 2004;7:109-124.
3. Perlmutter DH, Shepherd RW. Extrahepatic biliary atresia: a disease or a phenotype? HEPATOLOGY 2002;35:1297-1304.
4. Petersen C. Pathogenesis and treatment opportunities lor biliary atresia. Clin Liver Dis 2006;10:73-88, vi.
5. Maisels MJ. Jaundice. In: MacDonald MG, Seshia MMK, Mullett MD, eds. Avery's Neonatology. Philadelphia, PA: Lippincott; 2005:768-846.
6. Palmer RH, Ezhuthachan S, Newman C, Maisels MJ, Testa MA. Management of hyperbilirubinemia in newborns: measuring performance using a benchmarking model. Pediatrics 2004;114:902.
7. Maisels MJ, Kring E. Risk of sepsis in newborns with severe hyperbilirubinemia. Pediatrics 1992;90:741-743.
8. Alonso EM, Whitington PF, Whitington SH, Rivard WA, Given G. Enterohepatic circulation of nonconjugated bilirubin in rats fed with human milk. J Pediatr 1991;118:425-430.
9. Gourley GR, Li Z, Kreamer BL, Kosorok MR. A controlled, randomized, double-blind trial of prophylaxis against jaundice among breastfed newborns. Pediatrics 2005;116:385-391.
10. Monaghan G, McLellan A, McGeehan A, Li Volti S, Mollica F, Salemi I, et al. Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn. J Pediatr 1999;134:441-446.
11. Huang MJ, Kua KE, Teng HC, Tang KS, Weng HW, Huang CS. Risk factors for severe hyperbilirubinemia in neonates. Pediatr Res 2004;56: 682-689.
12. Thomson J. On congenital obliteration of the bile ducts. Edinburgh Med J 1892;37:604-616, 724-735.
13. Kasai M, Suzuki S. A new operation for "non-correctable" biliary atresia-portoenterostomy. Shijitsu 1959;13:733-739.
14. Shneider BL, Brown MB, Haber B, Whitington PF, Schwarz K, Squires R, et al. A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr 2006;148:467-474.
15. Chardot C, Carton M, Spire-Bendelac N, Le Pommelet C, Golmard JL, Auvert B. Epidemiology of biliary atresia in France: a national study 1986-96. J Hepatol 1999;31:1006-1013.
16. Davenport M, Kerkar N, Mieli-Vergani G, Mowat AP, Howard ER. Biliary atresia: the King's College Hospital experience (1974-1995). J Pediatr Surg 1997;32:479-485.
17. Hadzic N, Davenport M, Tizzard S, Singer J, Howard ER, Mieli-Vergani G. Long-term survival following Kasai portoenterostomy: is chronic liver disease inevitable? J Pediatr Gastroenterol Nutr 2003;37:430-433.
18. Nio M, Ohi R, Miyano T, Saeki M, Shiraki K, Tanaka K. Five- and 10-year survival rates after surgery for biliary atresia: a report from the Japanese Biliary Atresia Registry. J Pediatr Surg 2003;38:997-1000.
19. Ryckman F, Fisher R, Pedersen S, Dittrich V, Heubi J, Farrell M, et al. Improved survival in biliary atresia patients in the present era of liver transplantation. J Pediatr Surg 1993;28:382-385; discussion, 386.
20. Strickland AD, Shannon K. Studies in the etiology of extrahepatic biliary atresia: time-space clustering. J Pediatr 1982;100:749-753.
21. Harper P, Plant JW, Unger DB. Congenital biliary atresia and jaundice in lambs and calves. Aust Vet J 1990;67:18-22.
22. Caton AR, Druschel CM, McNutt LA. The epidemiology of extrahepatic biliary atresia in New York State, 1983-98. Paediatr Perinat Epidemiol 2004;18:97-105.
23. Chardot C, Carton M, Spire-Bendelac N, Le Pommelet C, Golmard JL, Auvert B. Prognosis of biliary atresia in the era of liver transplantation: French national study from 1986 to 1996. HEPATOLOGY 1999;30:606-611.
24. Ibrahim M, Miyano T, Ohi R, Saeki M, Shiraki K, Tanaka K, et al. Japanese Biliary Atresia Registry, 1989 to 1994. Tohoku J Exp Med 1997;181:85-95.
25. Karrer FM, Lilly JR, Stewart BA, Hall RJ. Biliary atresia registry, 1976 to 1989. J Pediatr Surg 1990;25:1076-1080; discussion, 1081.
26. McKiernan PJ, Baker AJ, Kelly DA. The frequency and outcome of biliary atresia in the UK and Ireland. Lancet 2000;355:25-29.
27. Fischler B, Haglund B, Hjern A. A population-based study on the incidence and possible pre- and perinatal etiologic risk factors of biliary atresia. J Pediatr 2002;141:217-222.
28. Lee H, Lewis J, Schoen BT, Brand T, Ricketts RR. Kasai portoenterostomy: differences related to race. J Pediatr Surg 2001;36:1196-1198.
29. Carmi R, Magee CA, Neill CA, Karrer FM. Extrahepatic biliary atresia and associated anomalies: etiologic heterogeneiry suggested by distinctive patterns of associations. Am J Med Genet 1993;45:683-693.
30. Silveira TR, Salzano FM, Howard ER, Mowat AP. Congenital structural abnormalities in biliary atresia: evidence for etiopathogenic heterogeneity and therapeutic implications. Acta Paediatr Scand 1991;80:1192-1199.
31. Arvay JL, Zemel BS, Gallagher PR, Rovner AJ, Mulberg AE, Stallings VA, et al. Body composition of children aged 1 to 12 years with biliary atresia or Alagille syndrome. J Pediatr Gastroenterol Nutr 2005;40:146-150.
32. Sokol RJ, Stall C. Anthropometric evaluation of children with chronic liver disease. Am J Clin Nutr 1990;52:203-208.
33. DeRusso P, Ye W, Haber BA, Shneider B, Sokol RJ, Whitington PF, et al. Early growth failure following hepatoportoenterostomy is associated with liver transplantation or death in infants with biliary atresia. HEPATOLOGY 2005;42(Suppl 1):A64.
34. Moyer V, Freese DK, Whitington PF, Olson AD, Brewer F, Colletti RB, et al. Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2004;39: 115-128.
35. Tan Kendrick AP, Phua KB, Ooi BC, Subramaniam R, Tan CE, Goh AS. Making the diagnosis of biliary atresia using the triangular cord sign and gallbladder length. Pediatr Radiol 2000;30:69-73.
36. Liu CS, Chin TW, Wei CF. Value of gamma-glutamyl transpeptidase for early diagnosis of biliary atresia. Zhonghua Yi Xue Za Zhi (Taipei) 1998; 61:716-720.
37. Shteyer E, Ramm GA, Xu C, White FV, Shepherd RW. Outcome after portoenterostomy in biliary atresia: pivotal role of degree of liver fibrosis and intensity of stellate cell activation. J Pediatr Gastroenterol Nutr 2006; 42:93-99.
38. De Matos V, Erlichman J, Russo PA, Haber BA. Does "cystic" biliary atresia represent a distinct clinical and etiological subgroup? A series of three cases. Pediatr Dev Pathol 2005;8:725-731.
39. Davenport M, Tizzard SA, Underhill J, Mieli-Vergani G, Portmann B, Hadzic N. The biliary atresia splenic malformation syndrome: a 28-year single-center retrospective study. J Pediatr 2006;149:393-400.
40. Kasai M, Kimura S, Assecura Y. Surgical treatment of biliary atresia. J Pediatr Surg 1968;3:665-675.
41. Campbell DP, Smith EI, Bhatia M, Foley JR, Williams GR. Hepatic portoenterostomy: an assessment of its value in the treatment of biliary atresia. Ann Surg 1975;181:591-595.
42. Altman RP. The portoenterostomy procedure for biliary atresia: a five year experience. Ann Surg 1978;188:351-362.
43. Carcassonne M, Bensoussan A. Long-term results in treatment of biliary atresia. Prog Pediarr Surg 1977;10:151-160.
44. Howard ER, Driver M, McClement J, Mowat AP. Results of surgery in 88 consecutive cases of extrahepatic biliary atresia. J R Soc Med 1982;75: 408-413.
45. Mustard R Jr, Shandling B, Gillam J. The Kasai operation (hepatic portoenterostomy) for biliary atresia-experience with 20 cases. J Pediatr Surg 1979;14:511-514.
46. Kasai M. Advances in treatment of biliary atresia. Jpn J Surg 1983;13: 265-276.
47. Suruga K, Miyano T, Kitahara T, Kojima Y, Fukuda Y. Treatment of biliary atresia: a study of our operative results. J Pediatr Surg 1981;16: 621-626.
48. Saeki M, Nakano M, Hagane K, Shimizu K. Effectiveness of an intussusceptive antireflux valve to prevent ascending cholangitis after hepatic portojejunostomy in biliary atresia. J Pediatr Surg 1991;26:800-803.
49. Tanaka K, Shirahase I, Utsunomiya H, Katayama T, Uemoto S, Asonuma K, et al. A valved hepatic portoduodenal intestinal conduit for biliary atresia. Ann Surg 1991;213:230-235.
50. Ogasawara Y, Yamataka A, Tsukamoto K, Okada Y, Lane GJ, Kobayashi H, et al. The intussusception antireflux valve is ineffective for preventing cholangitis in biliary atresia: a prospective study. J Pediatr Surg 2003;38: 1826-1829.
51. Azarow KS, Phillips MJ, Sandler AD, Hagerstrand I, Superina RA. Biliary atresia: should all patients undergo a portoenterostomy? J Pediatr Surg 1997;32:168-172; discussion 172-164.
52. Lang T, Kappler M, Dietz H, Harms HK, Bertele-Harms R. Biliary atresia: which factors predict the success of a Kasai operation? An analysis of 36 patients. Eur J Med Res 2000;5:110-114.
53. Serinet MO, Broue P, Jacquemin E, Lachaux A, Sarles J, Gotttand F, et al. Management of patients with biliary atresia in France: results of a decentralized policy 1986-2002. HEPATOLOGY 2006;44:75-84.
54. Altman RP, Lilly JR, Greenfeld J, Weinberg A, van Leeuwen K, Flanigan L. A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia: twenty-five years of experience from two centers. Ann Surg 1997;226:348-353; discussion 353-345.
55. Utterson EC, Shepherd RW, Sokol RJ, Bucuvalas J, Magee JC, McDiarmid SV, et al. Biliary atresia: clinical profiles, risk factors, and outcomes of 755 patients listed for liver transplantation. J Pediatr 2005;147:180-185.
56. McLin VA, Zorn AM. Molecular control of liver development. Clin Liver Dis 2006;10:1-25.
57. Fjaer RB, Bruu AL, Nordbo SA. Extrahepatic bile duct atresia and viral involvement. Pediatr Transplant 2005;9:68-73.
58. Fischler B, Ehrnst A, Forsgren M, Orvell C, Nemeth A. The viral association of neonatal cholestasis in Sweden: a possible link between cytomegalovirus infection and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr 1998;27:57-64.
59. Tarr PI, Haas JE, Christie DL. Biliary atresia, cytomegalovirus, and age at referral. Pediatrics 1996;97:828-831.
60. Jevon GP, Dimmick JE. Biliary atresia and cytomegalovirus infection: a DNA study. Pediatr Dev Pathol 1999;2:11-14.
61. Morecki R, Glaser JH, Cho S, Balistreri WF, Horwitz MS. Biliary atresia and reovirus type 3 infection. N Engl J Med 1984;310:1610.
62. Morecki R, Glaser JH, Johnson AB, Kress Y. Detection of reovirus type 3 in the porta hepatis of an infant with extrahepatic biliary atresia: ultrastructural and immunocytochemical study. HEPATOLOGY 1984;4:1137-1142.
63. Richardson SC, Bishop RF, Smith AL. Reovirus serotype 3 infection in infants with extrahepatic biliary atresia or neonatal hepatitis. J Gastroenterol Hepatol 1994;9:264-268.
64. Steele MI, Marshall CM, Lloyd RE, Randolph VE. Reovirus 3 not detected by reverse transcriptase-mediated polymerase chain reaction analysis of preserved tissue from infants with cholestatic liver disease. HEPATOLOGY 1995;21:697-702.
65. Tyler KL, Sokol RJ, Oberhaus SM, Le M, Karrer FM, Narkewicz MR, et al. Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts. HEPATOLOGY 1998;27: 1475-1482.
66. Bangaru B, Morecki R, Glaser JH, Gartner LM, Horwitz MS. Comparative studies of biliary atresia in the human newborn and reovirus-induced cholangitis in weanling mice. Lab Invest 1980;43:456-462.
67. Wilson GA, Morrison LA, Fields BN. Association of the reovirus S1 gene with serotype 3-induced biliary atresia in mice. J Virol 1994;68:6458-6465.
68. Szavay PO, Leonhardt J, Czech-Schmidt G, Petersen C. The role of reovirus type 3 infection in an established murine model for biliary atresia. Eur J Pediatr Surg 2002;12:248-250.
69. Bobo L, Ojeh C, Chiu D, Machado A, Colombani P, Schwarz K. Lack of evidence for rotavirus by polymerase chain reaction/enzyme immunoassay of hepatobiliary samples from children with biliary atresia. Pediatr Res 1997;41:229-234.
70. Riepenhoff-Talty M, Gouvea V, Evans MJ, Svensson L, Hoffenberg E, Sokol RJ, et al. Detection of group C rotavirus in infants with extrahepatic biliary atresia. J Infect Dis 1996;174:8-15.
71. Petersen C, Biermanns D, Kuske M, Schakel K, Meyer-Junghanel L, Mildenberger H. New aspects in a murine model for extrahepatic biliary atresia. J Pediatr Surg 1997;32:1190-1195.
72. Riepenhoff-Talty M, Schaekel K, Clark HF, Mueller W, Uhnoo I, Rossi T, et al. Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res 1993;33:394-399.
73. Bezerra JA, Tiao G, Ryckman FC, Alonso M, Sabla GE, Shneider B, et al. Genetic induction of proinflammatory immunity in children with biliary atresia. Lancet 2002;360:1653-1659.
74. Mack CL, Tucker RM, Sokol RJ, Karrer FM, Kotzin BL, Whitington PF, et al. Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation. Pediatr Res 2004;56:79-87.
75. Shivakumar P, Campbell KM, Sabla GE, Miethke A, Tiao G, McNeal MM, et al. Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia. J Clin Invest 2004;114:322-329.
76. Davenport M, Savage M, Mowat AP, Howard ER. Biliary atresia splenic malformation syndrome: an etiologic and prognostic subgroup. Surgery 1993;113:662-668.
77. Mazziotti MV, Willis LK, Heuckeroth RO, LaRegina MC, Swanson PE, Overbeek PA, et al. Anomalous development of the hepatobiliary system in the Inv mouse. HEPATOLOGY 1999;30:372-378.
78. Yokoyama T, Copeland NG, Jenkins NA, Montgomery CA, Elder FF, Overbeek PA. Reversal of left-right asymmetry: a situs inversus mutation. Science 1993;260:679-682.
79. Schon P, Tsuchiya K, Lenoir D, Mochizuki T, Guichard C, Takai S, et al. Identification, genomic organization, chromosomal mapping and mutation analysis of the human INV gene, the ortholog of a murine gene implicated in left-right axis development and biliary atresia. Hum Genet 2002;110:157-165.
80. Ware SM, Peng J, Zhu L, Fernbach S, Colicos S, Casey B, et al. Identification and functional analysis of ZIC3 mutations in heterotaxy and related congenital heart defects. Am J Hum Genet 2004;74:93-105.
81. Jacquemin E, Cresteil D, Raynaud N, Hadchouel M. CFCI gene mutation and biliary atresia with polysplenia syndrome. J Pediatr Gastroenterol Nutr 2002;34:326-327.
82. Kohsaka T, Yuan ZR, Guo SX, Tagawa M, Nakamura A, Nakano M, et al. The significance of human jagged 1 mutations detected in severe cases of extrahepatic biliary atresia. HEPATOLOGY 2002;36:904-912.
83. Ku NO, Darling JM, Krams SM, Esquivel CO, Keeffe EB, Sibley RK, et al. Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies. Proc Natl Acad Sci U S A 2003;100:6063-6068.
84. Chen L, Goryachev A, Sun J, Kim P, Zhang H, Phillips MJ, et al. Altered expression of genes involved in hepatic morphogenesis and fibrogenesis are identified by cDNA microarray analysis in biliary atresia. HEPATOLOGY 2003;38:567-576.
85. Carvalho E, Liu C, Shivakumar P, Sabla G, Aronow B, Bezerra JA. Analysis of the biliary transcriptome in experimental biliary atresia. Gastroenterology 2005;129:713-717.
86. Campbell KM, Sabla GE, Bezerra JA. Transcriptional reprogramming in murine liver defines the physiologic consequences of biliary obstruction. J Hepatol 2004;40:14-23.
87. Wang H, Vohra BP, Zhang Y, Heuckeroth RO. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice. HEPATOLOGY 2005;42:1099-1108.
88. Zhang DY, Sabla G, Shivakumar P, Tiao G, Sokol RJ, Mack C, et al. Coordinate expression of regulatory genes differentiates embryonic and perinatal forms of biliary atresia. HEPATOLOGY 2004;39:954-962.
89. Kasai M, Suzuki H, Ohashi E, Ohi R, Chiba T, Okamoto A. Technique and results of operative management of biliary atresia. World J Surg 1978;2:571-579.
90. Powell JE, Keffler S, Kelly DA, Green A. Population screening for neonatal liver disease: potential for a community-based programme. J Med Screen 2003;10:112-116.
91. Chen SM, Chang MH, Du JC, Lin CC, Chen AC, Lee HC, et al. Screening for biliary atresia by infant stool color card in Taiwan. Pediatrics 2006;117:1147-1154.
92. Davenport M, De Ville de Goyet J, Stringer MD, Mieli-Vergani G, Kelly DA, McClean P, et al. Seamless management of biliary atresia in England and Wales (1999-2002). Lancet 2004;363:1354-1357.
93. Muraji T, Nio M, Ohhama Y, Hashimoto T, Iwanaka T, Takamatsu H, et al. Postoperative corticosteroid therapy for bile drainage in biliary atresia - a nationwide survey. J Pediatr Surg 2004;39:1803-1805.
94. Shepherd RW. Pre- and postoperative nutritional care in liver transplantation in children. J Gastroenterol Hepatol 1996;11:S7-S10.
95. Greer R, Lehnert M, Lewindon P, Cleghorn GJ, Shepherd RW. Body composition and components of energy expenditure in children with end-stage liver disease. J Pediatr Gastroenterol Nutr 2003;36:358-363.
96. Chin SE, Shepherd RW, Thomas BJ, Cleghorn GJ, Patrick MK, Wilcox JA, et al. The nature of malnutrition in children with end-stage liver disease awaiting orthotopic liver transplantation. Am J Clin Nutr 1992;56:164-168.
97. Chin SE, Shepherd RW, Thomas BJ, Cleghorn GJ, Patrick MK, Wilcox JA, et al. Nutritional support in children with end-stage liver disease: a randomized crossover trial of a branched-chain amino acid supplement. Am J Clin Nutr 1992;56:158-163.
98. Alonso EM, Neighbors K, Mattson C, Sweet E, Ruch-Ross H, Berry C, et al. Functional outcomes of pediatric liver transplantation. J Pediatr Gastroenterol Nutr 2003;37:155-160.
99. Midgley DE, Bradlee TA, Donohoe C, Kent KP, Alonso EM. Health-related quality of life in long-term survivors of pediatric liver transplantation. Liver Transpl 2000;6:333-339.
100. Serving the family from birth to the medical home. Newborn screening: a blueprint for the future - a call for a national agenda on state newborn screening programs. Pediatrics 2000;106:389-422.
101. Newborn screening: toward a uniform screening panel and system. Genet Med 2006;8(Suppl 1):S1-S252.
102. Therrell BL Jr. U.S. newborn screening policy dilemmas for the twenty-first century. Mol Genet Metab 2001;74:64-74.
103. Suchy FJ, Balistreri WF, Heubi JE, Searcy JE, Levin RS. Physiologic cholestasis: elevation of the primary serum bile acid concentrations in normal infants. Gastroenterology 1981;80:1037-1041.
104. Javitt NB, Keating JP, Grand RJ, Harris RC. Serum bile acid patterns in neonatal hepatitis and extrahepatic biliary atresia. J Pediatr 1977;90:736-739.
105. Balistreri WF, Suchy FJ, Farrell MK, Heubi JE. Pathologic versus physiologic cholestasis: elevated serum concentration of a secondary bile acid in the presence of hepatobiliary disease. J Pediatr 1981;98:399-402.
106. Matsui A, Fujimoto T, Takazawa Y, Okaniwa M, Kamoshita S. Serum bile acid levels in patients with extrahepatic biliary atresia and neonatal hepatitis during the first 10 days of life. J Pediatr 1985;107:255-257.
107. Tazawa Y, Yamada M, Nakagawa M, Konno T, Tada K. Serum bile acid patterns determined by an enzymatic method and high-performance liquid chromatography in young infants with cholestasis. J Pediatr Gastroenterol Nutr 1984;3:394-401.
108. Mushtaq I, Logan S, Morris M, Johnson AW, Wade AM, Kelly D, et al. Screening of newborn infants for cholesratic hepatobiliary disease with tandem mass spectrometry. BMJ 1999;319:471-477.
109. Gustafsson J, Alvelius G, Bjorkhem I, Nemeth A. Bile acid metabolism in extrahepatic biliary atresia: lithocholic acid in stored dried blood collected at neonatal screening. Ups J Med Sci 2006;111:131-136.
110. Tazawa Y, Yamada M, Nakagawa M, Konno Y, Tada K. Unconjugated, glycine-conjugated, taurine-conjugated bile acid nonsulfates and sulfates in urine of young infants with cholestasis. Acta Paediatr Scand 1984;73: 392-397.
111. Matsui A, KasanoY, Yamauchi Y, Momoya T, Shimada T, Ishikawa T, et al. Direct enzymatic assay of urinary sulfated bile acids to replace serum bilirubin testing for selective screening of neonatal cholestasis. J Pediatr 1996;129:306-308.
112. Muraji T, Harada T, Miki K, Moriuchi T, Obatake M, Tsugawa C. Urinary sulfated bile acid concentrations in infants with biliary atresia and breast-feeding jaundice. Pediatr Int 2003;45:281-283.
113. Nittono H, Obinata K, Nakatsu N, Watanabe T, Niijima S, Sasaki H, et al. Sulfated and nonsulfated bile acids in urine of patients with biliary atresia: analysis of bile acids by high-performance liquid chromatography. J Pediatr Gastroenterol Nutr 1986;5:23-29.
114. Yousef IM, Perwaiz S, Lamireau T, Tuchweber B. Urinary bile acid profile in children with inborn errors of bile acid metabolism and chronic cholestasis; screening technique using electrospray tandem mass-spectrometry (ES/MS/MS). Med Sci Monit 2003;9:MT21-MT31.
115. Keffler S, Kelly DA, Powell JE, Green A. Population screening for neonatal liver disease: a feasibility study. J Pediatr Gastroenterol Nutr 1998; 27:306-311.
116. Matsui A, Dodoriki M. Screening for biliary atresia. Lancet 1995;345:1181.
117. Matsui A, Ishikawa T. Identification of infants with biliary atresia in Japan. Lancet 1994;343:925.
118. Maki T, Sumazaki R, Matsui A. Mass screening for biliary atresia. Jpn J Pediatr Surg 1999;31:242-246.
119. Hung PY, Chen CC, Chen WJ, Lai HS, Hsu WM, Lee PH, et al. Long-term prognosis of patients with biliary atresia: a 25 year summary. J Pediatr Gastroenterol Nutr 2006;42:190-195.
120. Ramonet M, Gomez S, Ramos S, Morise S, Parga L, Caglio P, et al. Stool color card screening for infants aged one month. J Pediatr Gastroenterol Nutr 2004;39:S137-S138.
121. Sokol RJ, Mack C, Narkewicz MR, Karrer FM. Pathogenesis and outcome of biliary atresia: current concepts. J Pediatr Gastroenterol Nutr 2003;37:4-21.